ABC transporters are molecular pumps found in virtually every living organism, from bacteria to plants to humans, and they move an enormous range of substances across cell membranes using the energy stored in ATP. The name stands for “ATP-binding cassette,” referring to a shared structural module that burns ATP as fuel. In the human body alone, there are 48 distinct ABC transporters, and they do everything from ejecting toxins out of cells to shuttling cholesterol, delivering immune signals, and forming bile. Their reach is so broad that when they malfunction, the consequences range from cystic fibrosis to drug-resistant cancer.
The Shared Blueprint
Despite the variety of jobs they perform, all ABC transporters share a common architecture built from four core parts: two sections that span the cell membrane (transmembrane domains) and two sections that sit inside the cell and bind ATP (nucleotide-binding domains).1PubMed Central. Structure and mechanism of ABC transporters The transmembrane domains form a pathway through the membrane’s oily interior, creating a channel that cargo can pass through. The nucleotide-binding domains act as the engine, grabbing and breaking down ATP molecules to power the pump. One hallmark that distinguishes ABC transporters from all other proteins is a short amino acid sequence called the LSGGQ motif, which is involved in gripping ATP and is so well conserved across species that finding it in a gene is essentially proof you are looking at an ABC transporter.2PubMed Central. Structure and mechanism of ABC transporters
These four parts can be encoded on a single gene as one large protein or on separate genes whose products assemble like Lego bricks. The membrane-spanning sections are where the diversity lives: their shapes differ dramatically depending on what each transporter needs to move, while the ATP-burning engine rooms are remarkably similar across the entire family.3PubMed Central. Mechanism of ABC transporters: a molecular dynamics simulation of a well characterized nucleotide-binding subunit
How the Pump Cycle Works
The basic pumping action is surprisingly mechanical. Think of a revolving door that can only turn when you insert a coin. At rest, the transporter sits in an “inward-facing” shape, with its channel open toward the inside of the cell. When a cargo molecule slips into this opening, and ATP binds to the engine domains, those engine domains clamp together tightly. That clamping forces the membrane-spanning sections to flip, closing the inward opening and creating a new opening on the opposite side of the membrane. The cargo is now exposed to the outside (or the interior of an organelle, depending on the transporter) and gets released.4ACS Central Science. Molecular Mechanism of ATP Hydrolysis in an ABC Transporter
Once the cargo is gone, the transporter has to reset. ATP is broken down into ADP and a phosphate group, and that breakdown loosens the engine domains, allowing the whole structure to spring back to its inward-facing starting position, ready for the next cycle.5PubMed Central. Structural insights into ABC transporter mechanism Both importers and exporters share this alternating-access cycle, flipping between inward-facing and outward-facing shapes. In bacteria, importers that pull nutrients into the cell also rely on an extra helper protein outside the cell that captures the cargo and delivers it to the transporter’s entrance, a feature not found in exporters.6PubMed Central. ATP-binding cassette (ABC) transporters: structures and roles in bacterial pathogenesis
How One Pump Handles Hundreds of Different Drugs
One of the most surprising things about certain ABC transporters is their ability to recognize and move an almost absurdly diverse set of molecules. The best-studied example is P-glycoprotein (also called ABCB1 or P-gp), which can pump out chemotherapy drugs, antibiotics, steroids, HIV protease inhibitors, and even some food compounds. Crystal structures of P-glycoprotein reveal the trick: its cargo-binding pocket sits inside a large, flexible cavity between the two membrane-spanning halves, and the walls of this cavity constantly shift shape as the pump cycles through its motions.7Journal of Biological Chemistry. Structure of a linker-shortened mouse P-glycoprotein reveals a mechanism for polyspecificity
The pocket’s lining is mostly made of amino acids that interact well with greasy, hydrophobic molecules, which is why P-glycoprotein tends to grab drugs that dissolve easily in the membrane’s lipid environment. But because the helices that form the pocket rotate and rearrange during each cycle, the binding surface is never exactly the same twice. Researchers have described this as a “continuously changing landscape” that can interact with an effectively unlimited number of substrates.8Journal of Biological Chemistry. Structure of a linker-shortened mouse P-glycoprotein reveals a mechanism for polyspecificity Structural comparisons with bacterial relatives suggest that the helices undergo an axial twist that creates high-affinity binding when the pocket is inward-facing and low-affinity release when it flips outward, ensuring cargo gets picked up on one side and dropped on the other.9PubMed Central. Understanding polyspecificity of multidrug ABC transporters: closing in on the gaps in ABCB1
Cancer Drug Resistance
This polyspecificity is a huge problem in cancer treatment. Tumor cells that ramp up production of P-glycoprotein can pump chemotherapy drugs out faster than the drugs can kill the cell. The result is multidrug resistance, where a cancer that initially responds to treatment stops responding, sometimes to multiple unrelated drugs at once. Overexpression of P-glycoprotein has been detected across many types of chemoresistant cancer, and the protein can lower the intracellular concentration of a drug enough to render it ineffective.10PubMed Central. Mechanism of multidrug resistance to chemotherapy mediated by P‑glycoprotein
Researchers have spent decades trying to develop drugs that inhibit P-glycoprotein and restore sensitivity to chemotherapy. The idea is straightforward: block the pump and the anticancer drug stays inside the tumor cell long enough to work.11PubMed. Strategies to overcome cancer multidrug resistance (MDR) through targeting P-glycoprotein (ABCB1): An updated review In practice, though, first- and second-generation P-gp inhibitors ran into toxicity problems because P-glycoprotein also protects healthy tissues. Blocking it body-wide meant that normal cells lost their defense against toxins too. Newer strategies aim to deliver inhibitors specifically to tumor tissue or to use antibodies or nanoparticles that target the pump only where it is overexpressed.
Guarding the Brain
The blood-brain barrier is one of the places where ABC transporters earn their keep in healthy tissue. The endothelial cells lining brain capillaries are packed with P-glycoprotein and another ABC transporter called BCRP (ABCG2), both sitting on the blood-facing surface and actively pumping substances back into the bloodstream before they can reach brain tissue.12PubMed Central. Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier Studies in porcine brain capillaries found that BCRP is actually more strongly expressed than P-glycoprotein or another transporter called MRP1, and it appears to be the primary gatekeeper for excluding drugs like the chemotherapy agent daunorubicin from the central nervous system.13PubMed. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier
This creates a therapeutic double bind. The same pumps that protect the brain from environmental toxins also keep out drugs that doctors want to deliver there, including treatments for brain tumors, Alzheimer’s disease, and epilepsy. During inflammation, pro-inflammatory signals like IL-1β and TNF-α can reduce both BCRP and P-glycoprotein levels, which may temporarily let more substances cross into the brain.14PubMed Central. Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrier That is both a risk factor during infections and a clue that researchers are exploring to improve drug delivery to the brain.
Cystic Fibrosis and the Transporter That Became a Channel
Not every ABC transporter actually transports cargo in the traditional sense. CFTR, the protein mutated in cystic fibrosis, has the full ABC transporter architecture with two transmembrane domains and two nucleotide-binding domains, but it functions as an ion channel rather than a pump.15PubMed Central. Cystic fibrosis transmembrane conductance regulator (CFTR): Making an ion channel out of an active transporter structure It uses ATP binding and breakdown not to move cargo through a cycle but to open and close a gate that lets chloride ions flow passively across the membrane. When this channel does not work properly, the mucus lining the lungs, pancreas, and other organs becomes thick and sticky, leading to the hallmark symptoms of cystic fibrosis.
The most common mutation, called ΔF508, interferes with how CFTR folds into its correct three-dimensional shape. The protein gets stuck in quality control inside the cell and never reaches the surface where it is needed.16PubMed. Assembly of functional CFTR chloride channels The drug Trikafta, approved by the FDA, directly addresses this by combining three small molecules: one (elexacaftor) helps the misfolded protein escape the cell’s quality-control machinery, a second (tezacaftor) further stabilizes its structure, and a third (ivacaftor) holds the channel open once it reaches the cell surface. Together they increase CFTR activity enough to meaningfully reduce symptoms.17PubMed Central. A Review of Trikafta: Triple Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy Trikafta stands as one of the clearest examples of a drug designed around a detailed understanding of ABC transporter biology.
Immune Surveillance
Your immune system relies on ABC transporters to detect infected or cancerous cells. The transporter associated with antigen processing (TAP) is a heterodimer made of two ABC subunits, TAP1 and TAP2, and it sits in the membrane of the endoplasmic reticulum. Its job is to grab short protein fragments, called peptides, from the cell’s interior and ferry them into the ER, where they get loaded onto MHC class I molecules.18PubMed Central. Spotlight on TAP and its vital role in antigen presentation and cross-presentation Those MHC-peptide complexes then travel to the cell surface, where CD8+ T cells inspect them. If the peptide comes from a virus or a mutated protein, the T cell recognizes the cell as dangerous and kills it.
TAP transports nearly the entire repertoire of antigenic peptides that end up on MHC class I, making it a bottleneck for the whole process.19PubMed Central. Principles of peptide selection by the transporter associated with antigen processing Some viruses and tumors have evolved ways to downregulate TAP expression, which means fewer peptide fragments get displayed and the infected or cancerous cell becomes partially invisible to T cells. This is an active area of immunotherapy research: finding ways to restore TAP function could make tumors more visible to the immune system.
Cholesterol and Bile
Several ABC transporters are central players in lipid metabolism. ABCA1 moves cholesterol and phospholipids out of cells onto a carrier protein in the blood called apolipoprotein A-I, which is the first step in forming HDL, the so-called “good cholesterol” particles. Two related transporters, ABCG1 and ABCG4, handle the next stage by loading additional cholesterol onto HDL particles that already have some lipid cargo.20Journal of Lipid Research. ABCG1 and ABCG4 act in tandem with ABCA1 to generate high density lipoprotein particles Mutations in ABCA1 cause Tangier disease, a rare condition in which HDL levels are almost undetectable and cholesterol accumulates in tissues throughout the body.
In the liver, a different set of ABC transporters drives bile formation. ABCB11 is the main bile salt export pump, pushing conjugated bile acids from liver cells into the bile ducts. This transport not only protects the liver from bile acid toxicity but is the primary force that keeps bile flowing. A neighboring transporter, ABCB4, secretes phosphatidylcholine into the bile, where it combines with bile acids and cholesterol to form stable mixed structures that prevent bile acids from damaging the lining of the bile ducts.21Drug Metabolism and Disposition. The Role of Canalicular ABC Transporters in Cholestasis – Section: ABCB11 When either of these transporters fails, bile formation goes wrong and the result is cholestasis, a condition where bile backs up into the liver and causes progressive damage.
Bacterial Virulence and Antifungal Resistance
Bacteria are loaded with ABC transporters, and many are directly tied to how well a pathogen can infect a host. In uropathogenic E. coli, the ABC family is overrepresented among the genes needed for fitness in the urinary tract. Researchers found that knocking out individual ABC transport systems produced only modest effects, but disabling multiple systems together caused substantial fitness defects, suggesting these transporters back each other up through genetic compensation.22PubMed Central. Emerging roles for ABC transporters as virulence factors in uropathogenic Escherichia coli Bacterial ABC importers pull in essential nutrients like metal ions, amino acids, and vitamins, while exporters push out toxins, contribute to antimicrobial resistance, and secrete virulence factors needed for infection.23PubMed. The role of bacterial ATP-binding cassette (ABC) transporters in pathogenesis and virulence: Therapeutic and vaccine potential
Fungi play the same game. Candida albicans, one of the most common fungal pathogens in humans, uses an ABC transporter called Cdr1 as its primary weapon against antifungal drugs. Cdr1 pumps azole antifungals out of the fungal cell, lowering the drug’s effectiveness much the way P-glycoprotein does in cancer cells.24PubMed Central. The ABCs of Candida albicans Multidrug Transporter Cdr1 In Candida glabrata, another species increasingly seen in hospitals, three ABC transporters (Cdr1, Pdh1, and Snq2) all contribute to azole resistance, with Cdr1 again being the most important.25PubMed Central. Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata The convergent evolution of ABC-mediated drug resistance across bacteria, fungi, and human cancer cells underscores how deeply these pumps are embedded in the survival strategies of living cells.
ABC Transporters in Plants
Plants rely on ABC transporters for an impressive range of functions that go well beyond detoxification, which is how they were first discovered in plant biology. In Arabidopsis, ABC transporters deposit waxy lipids on leaf surfaces, accumulate phytate in seeds, and transport the hormones auxin and abscisic acid that control growth and stress responses.26PubMed Central. Plant ABC Transporters They also contribute to pathogen resistance and help the plant cope with drought, salt, and heavy metals. Recent cryo-electron microscopy work on a plant ABCB transporter showed that its activity in a lipid membrane environment was dramatically higher than when studied in detergent, a reminder that the surrounding lipid environment profoundly affects how these pumps work.27PubMed Central. Conformational cycle and small-molecule inhibition mechanism of a plant ABCB transporter in lipid membranes
The Lipid Environment as an Allosteric Partner
That observation about lipids is not just a technical quirk of laboratory methods. The composition of the membrane surrounding an ABC transporter actively regulates how well it functions. Cholesterol, which is a substrate for some ABC transporters, also modulates the activity of others by altering the physical properties of the membrane patch they sit in.28PubMed. Transport of lipids by ABC proteins: interactions and implications for cellular toxicity, viability and function Experiments on a well-studied bacterial ABC importer showed that when the transporter was surrounded by phospholipids with short hydrocarbon tails, it became unstable and burned through ATP wastefully without actually moving cargo. Longer-tailed lipids stabilized the transporter, slowed down its ATP consumption, and restored proper coupling between ATP use and cargo transport.29PubMed. The maltose ABC transporter: action of membrane lipids on the transporter stability, coupling and ATPase activity In another bacterial exporter, negatively charged lipids were required for function, while zwitterionic lipids provided structural stability.30Journal of Biological Chemistry. Structure of an antibacterial peptide ATP-binding cassette transporter in a novel outward occluded state
The practical implication is that understanding ABC transporter behavior requires understanding the membrane it lives in. A drug designed to inhibit P-glycoprotein might behave differently depending on the lipid makeup of the target tissue, and disease states that alter membrane composition could change how well these pumps protect cells.
ABC Proteins That Do Not Transport Anything
Some members of the ABC superfamily have abandoned transport altogether and repurposed the ATP-driven conformational cycle for completely different tasks. The most striking example is ABCE1, which has nothing to do with membranes and instead works inside the cell’s protein-making machinery. After a ribosome finishes translating a protein, ABCE1 uses ATP to pry apart the ribosome’s two subunits so they can be recycled for a new round of translation.31PubMed Central. The role of ABCE1 in eukaryotic posttermination ribosomal recycling It does this by splitting the ribosome into its large and small subunits while the messenger RNA and transfer RNA remain attached to the small subunit.
ABCE1 is conserved across all eukaryotes and archaea and is essential for life. It contains an iron-sulfur cluster domain, an unusual feature for an ABC protein, and both this domain and its ATP-driven shape change are required for it to bind and disassemble the ribosome.32PubMed Central. Ribosome recycling depends on a mechanistic link between the FeS cluster domain and a conformational switch of the twin-ATPase ABCE1 The existence of ABCE1 shows that the ABC engine is a versatile mechanical device: the ability to change shape in response to ATP is useful far beyond pumping molecules across a membrane.
Inside the Cell’s Own Compartments
ABC transporters also operate on the membranes of organelles within the cell, not just the outer cell membrane. In mitochondria, an ABC transporter called ABCB7 exports a still-unidentified molecule that signals the cell about how much iron the mitochondria have available. This signal feeds into the regulatory system that controls iron use throughout the cell, including the production of heme, the oxygen-carrying component of hemoglobin.33PubMed Central. Erythropoiesis and iron sulfur cluster biogenesis When ABCB7 does not work properly, iron-sulfur cluster assembly goes wrong, and the downstream effects ripple through red blood cell production.
A related mitochondrial ABC transporter in the parasite Leishmania, called LmABCB3, is required for both heme synthesis and cytosolic iron-sulfur cluster assembly, and it can substitute for the yeast version of ABCB7 in experiments, demonstrating how conserved this mitochondrial role is across very distantly related organisms.34PubMed Central. LmABCB3, an atypical mitochondrial ABC transporter essential for Leishmania major virulence, acts in heme and cytosolic iron/sulfur clusters biogenesis
Engineering ABC Transporters for Biotechnology
The same pumping power that makes ABC transporters a headache in drug resistance is being turned into an advantage in industrial biotechnology. When microbes are engineered to produce valuable chemicals like biofuels, fragrances, or pigments, the products often accumulate inside the cell and eventually become toxic, slowing or killing the factory. Overexpressing or engineering ABC efflux transporters can relieve this bottleneck by continuously pumping the product out of the cell as it is made.35PubMed. Efflux Transporters’ Engineering and Their Application in Microbial Production of Heterologous Metabolites
In one example, researchers engineered an endogenous ABC transporter in yeast to secrete β-carotene, a hydrophobic pigment, and found that boosting the cell’s ATP supply and tuning membrane flexibility alongside the transporter itself were both critical for getting meaningful export rates.36PubMed Central. Engineering endogenous ABC transporter with improving ATP supply and membrane flexibility enhances the secretion of β-carotene in Saccharomyces cerevisiae The lesson echoes what basic research has shown about lipid environments: the transporter does not work in isolation. The energy available and the physical properties of the membrane around it are equally important. As synthetic biology matures, ABC transporters are becoming a standard tool in the designer’s toolkit, their ancient versatility now harnessed for decidedly modern purposes.